SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-117074
Filing Date
2023-11-13
Accepted
2023-11-13 14:22:50
Documents
1
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2330403-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2330403-1_3seq1.xml 3 3880
  Complete submission text file 0001104659-23-117074.txt   5933
Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address
Pearson Mark E. (Reporting) CIK: 0001486558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 231397699

Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128 (408) 479-7842
Altamont Pharmaceutical Holdings, LLC (Reporting) CIK: 0001745878 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 231397700